HTLV-1 Tax transgenic mice develop spontaneous osteolytic bone metastases prevented by osteoclast inhibition.
about
Molecular basis for HEF1/NEDD9/Cas-L action as a multifunctional co-ordinator of invasion, apoptosis and cell cycleT-cell activation promotes tumorigenesis in inflammation-associated cancer.A novel bioluminescent mouse model and effective therapy for adult T-cell leukemia/lymphomaThe ARF tumor suppressor regulates bone remodeling and osteosarcoma development in mice.Direct antitumour activity of zoledronic acid: preclinical and clinical data.Integrins and bone metastasis: integrating tumor cell and stromal cell interactions.Animal Models Utilized in HTLV-1 ResearchIL-15 deficient tax mice reveal a role for IL-1α in tumor immunityMouse models of human T lymphotropic virus type-1-associated adult T-cell leukemia/lymphoma.Breast cancer cell targeting by prenylation inhibitors elucidated in living animals with a bioluminescence reporter.Animals Models of Human T Cell Leukemia Virus Type I Leukemogenesis.Cancer to bone: a fatal attraction.Interferon-gamma targets cancer cells and osteoclasts to prevent tumor-associated bone loss and bone metastases.Imaging spontaneous tumorigenesis: inflammation precedes development of peripheral NK tumors.In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP)Human T Lymphotropic Virus Type I (HTLV-I) Oncogenesis: Molecular Aspects of Virus and Host Interactions in Pathogenesis of Adult T cell Leukemia/Lymphoma (ATL).Osteoclastic miR-214 targets TRAF3 to contribute to osteolytic bone metastasis of breast cancer.The rise of metal radionuclides in medical imaging: copper-64, zirconium-89 and yttrium-86.Targeting HTLV-1 activation of NFκB in mouse models and ATLL patients.Animal models on HTLV-1 and related viruses: what did we learn?Expression of a protein involved in bone resorption, Dkk1, is activated by HTLV-1 bZIP factor through its activation domain.Targeting the alphavbeta3 integrin for small-animal PET/CT of osteolytic bone metastasesThe bisphosphonate zoledronic acid decreases tumor growth in bone in mice with defective osteoclasts.Bisphosphonate incadronate inhibits growth of human T-cell leukaemia virus type I-infected T-cell lines and primary adult T-cell leukaemia cells by interfering with the mevalonate pathway.HTLV-1 viral oncogene HBZ induces osteolytic bone disease in transgenic mice.Conference highlights of the 16th International Conference on Human Retrovirology: HTLV and related retroviruses, 26-30 June 2013, Montreal, Canada.Animal Models of Cancer-Associated Hypercalcemia.Mouse Models That Enhanced Our Understanding of Adult T Cell Leukemia.Animal Models of Bone Metastasis.The TP53-Induced Glycolysis and Apoptosis Regulator mediates cooperation between HTLV-1 p30II and the retroviral oncoproteins Tax and HBZ and is highly expressed in an in vivo xenograft model of HTLV-1-induced lymphoma.The HTLV-1 basic leucine zipper factor (HBZ) attenuates repair of double-stranded DNA breaks via non-homologous end joining (NHEJ).
P2860
Q28241105-9E84F680-26B6-476F-8773-236CD5A2F58BQ33590130-9B7ECE21-426A-4B37-87BA-BF0CD9A48F34Q33705439-F547EFCC-F998-43F1-90FB-FA61E5271CF0Q33786905-4137ECC6-5CAD-4348-ADD7-C64D3FB5FD0BQ33850938-6B73676D-D2A4-4483-A44A-38747E333BAFQ34441622-A474FEA3-D13A-48C0-A578-F4D591CCBC48Q34463104-475F1E5E-47FD-4707-9E0A-4B5185C1A558Q35085001-F9113561-A726-44FA-A73C-84A1841A5612Q35138158-1CD31A2B-62C8-43C9-9056-E518857C47E0Q36708774-9A1407ED-7BB2-424D-9FC2-DFAD21662EBEQ36751592-C31EB827-C65B-4542-97F6-5A723919CA22Q36884628-CC91C620-4F7F-49F2-8AE3-49192DE13D17Q37094204-A3B9768C-F78A-4C18-93F9-EDFAE77931C8Q37100728-7AA67185-8370-49EC-BACC-BF681FC29F39Q37122656-D390FE04-A1AC-4845-87D7-0910193D8B09Q37435369-A2FE288D-88A8-44F4-B2FA-D258088A484AQ37575983-FEB636A3-AA50-4D92-8AD4-440C39675BF3Q37869905-203E6CDA-AA86-4B7F-B9B1-7493E4256E5CQ37945228-C0348F75-BEF9-4FF5-89BF-328F1EF0B1FEQ38050763-A75D3F76-D667-4237-963B-03AD4280E42FQ38342243-8C803949-C7D5-4D2C-860A-098D915CD580Q39565634-3D4A171C-E8D5-4827-B383-46CEBD2930C0Q39851518-3055639A-310B-4007-B61C-53FE4FD8BE5AQ40181960-A2553167-7BAD-4D3A-A9F0-EE47F57EBB98Q42378329-D3B6C10F-30C2-400E-B496-DF5039DF7CEAQ42426735-8C07266C-6AB6-4797-9775-DF18B273B943Q43378586-79CD995E-BA3B-463F-86AF-B51973D08AC7Q52592925-0D724601-F57F-46CD-94C5-158263107F00Q53489280-C07463E3-6025-435F-A007-D327CCF0998BQ54205980-23454490-1AF3-4424-86D2-D8FD22EE1F9AQ54209627-C79939FE-91AF-4559-A4FE-C50734126364
P2860
HTLV-1 Tax transgenic mice develop spontaneous osteolytic bone metastases prevented by osteoclast inhibition.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
HTLV-1 Tax transgenic mice dev ...... nted by osteoclast inhibition.
@en
HTLV-1 Tax transgenic mice dev ...... nted by osteoclast inhibition.
@nl
type
label
HTLV-1 Tax transgenic mice dev ...... nted by osteoclast inhibition.
@en
HTLV-1 Tax transgenic mice dev ...... nted by osteoclast inhibition.
@nl
prefLabel
HTLV-1 Tax transgenic mice dev ...... nted by osteoclast inhibition.
@en
HTLV-1 Tax transgenic mice dev ...... nted by osteoclast inhibition.
@nl
P2093
P2860
P1433
P1476
HTLV-1 Tax transgenic mice dev ...... nted by osteoclast inhibition.
@en
P2093
Angela Hirbe
Haibo Zhao
Hongju Deng
John Harding
Katherine Weilbaecher
Lee Ratner
P2860
P304
P356
10.1182/BLOOD-2005-04-1730
P407
P577
2005-08-23T00:00:00Z